Flourescent biosensor-based, Cdc42 activity imaging for understanding the regulation of Epidermal Growth Receptor (EGFR) signalling in head and neck cancer
The Epidermal Growth Factor Receptor (EGFR) is overexpressed in several solid tumours including squamous cell carcinoma of the head & neck (SCCHN). Drugs that directly block the action of EGFR are currently available. However, a major unanswered question is; how best to select patients most...
Main Author: | Ofo, Enyinnaya |
---|---|
Published: |
King's College London (University of London)
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.628198 |
Similar Items
-
Anti-epidermal growth factor receptor (EGFR) therapy modelled in the mouse
by: Shaw, Paul H. S.
Published: (2010) -
Molecular targets in head and neck cancer
by: Qureishi, Ali Akhtar Siddique
Published: (2017) -
Prognostic biomarkers for head and neck squamous carcinoma
by: El-Attar, Radien
Published: (2013) -
The use of epidermal growth factor receptor activity biosensing to understand cancer gene network sensitivity and to monitor intratumoural heterogeneity
by: Cheung, Anthony
Published: (2013) -
The expression of a mutant epidermal growth factor receptor in prostatic tumours
by: Olapade-Olaopa, E. Oluwabunmi
Published: (2000)